Abrexa Pharmaceuticals, Inc.
2 registered trials on this site, 1 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of J147 in Acute Ischemic Stroke NCT07430917 | J-147 | Phase 2 | Recruiting | Abrexa Pharmaceuticals, Inc. | 196 | Mar 1, 2028 | Aug 24, 2026 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 NCT03838185 | J-147 | Phase 1 | Completed | Abrexa Pharmaceuticals, Inc. | 64 | Feb 1, 2020 | Sep 3, 2020 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
